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Abstract 
 
Background: We aimed to examine the association between chocolate intake and the risk of 
incident heart failure in a UK general population. We conducted a systematic review and 
meta-analysis to quantify this association.  
Methods and results: We used data from a prospective population-based study the European 
Prospective Investigation into Cancer (EPIC)-Norfolk cohort. Chocolate intake was quantified 
based on a food frequency questionnaire obtained at baseline (1993-1997) and incident heart 
failure was ascertained up to March 2009. We supplemented the primary data with a 
systematic review and meta-analysis of studies which evaluated risk of incident heart failure 
with chocolate consumption.  A total of 20,922 participants (53% women; mean age 58±9 
years) were included of whom 1,101 developed heart failure during the follow up (mean 
12.5±2.7 years, total person years 262,291 years). After adjusting lifestyle and dietary factors, 
we found 19% relative reduction in heart failure incidence in the top (up to 100g/d) compared 
to the bottom quintile of chocolate consumption (HR 0.81 95%CI 0.66-0.98) but the results 
were no longer significant after controlling for comorbidities (HR 0.87 95%CI 0.71-1.06). 
Additional adjustment for potential mediators did not attenuate the results further. We 
identified five relevant studies including the current study (N=75,408). The pooled results 
showed non-significant 19% relative risk reduction of heart failure incidence with higher 
chocolate consumption (HR 0.81 95%CI 0.66-1.01). 
Conclusions: Our results suggest that higher chocolate intake is not associated with 
subsequent incident heart failure.
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 Introduction 
Cocoa, one of the main ingredients in plain chocolate, is an important dietary source of 
flavonoids which are believed to have cardiovascular benefits.  Both observational and trial 
evidence have shown that chocolate consumption is associated with a reduction in blood 
pressure [1-4].  This reduction in blood pressure is thought to be due to enhancement of 
endothelial nitric oxide production[5,13] and inhibition of angiotensin converting enzyme 
[6,7]. Flavonoids also increase antioxidant capacity and diminish the production of oxidative 
products in the plasma8 and cocoa (one of the ingredients) has been shown to inhibit 
oxidation of low density lipoprotein (LDL) [9].  Moreover, the intake of chocolate and cocoa-
based products increases high density lipoprotein (HDL) cholesterol [10], reduces 
inflammation [11,12] and inhibits platelet aggregation [13]. Indeed, we have recently reported 
that habitual chocolate consumption is associated with lower cardiovascular risk [14]. These 
factors in combination may reduce the incidence of heart failure with higher chocolate 
consumption.  
Existing observational studies evaluating the risk of heart failure with chocolate 
consumption show conflicting results and are not directly applicable to the general 
population. They were conducted in highly selective populations such as women who 
underwent mammography [15], older women who received calcium therapy [16], in those 
after myocardial infarction [17], and among male physicians [18]. To date, there has not been 
a study on the general population which evaluates the relationship between habitual chocolate 
intake and subsequent risk of heart failure.  
In this paper, we report results from a large prospective UK population study, the 
European Prospective Investigation into Cancer-Norfolk (EPIC-Norfolk), and quantify the 
effect of chocolate consumption on heart failure incidence by conducting a systematic review 
and meta-analysis, including the current study. 
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Methods 
EPIC-Norfolk Cohort study 
 The study methods of the European Prospective Investigation into Cancer (EPIC)-
Norfolk have been previously described in detail.19 In brief, this is a prospective population 
study of 25,639 men and women, resident in Norfolk, United Kingdom (99.6% white 
Caucasian).  A baseline survey was conducted between 1993 and 1997.  Participants 
completed a health and lifestyle questionnaire and attended a health examination at their 
general practitioner’s clinic where a non-fasting venous blood sample was taken and stored. 
The data collection methods are described in Appendix 1.  Measurements of height, weight, 
body mass index; laboratory methods; ascertainment of education status, social class, self-
reported physical activity, smoking status, alcohol consumption,  and identification of 
participants’ co-morbid conditions using questionnaires have been described in previous 
studies [19-22]. A food frequency questionnaire (FFQ) was used to assess overall diet in the 
past year [23,24]. 
 A one year recall of chocolate consumption was  estimated using three questions from 
the FFQ and these questions were consumption of: “Chocolates singles or squares” (average 
portion size of 8 g), “Chocolate snack bars, e.g. Mars, Crunchie” (average portion size of 50 
g) and “Cocoa, hot chocolate (cup)” (average portion size of 12 g powder weight). The 
amount of chocolate product eaten (grams/day) was derived from multiplying the frequency 
categories by the portion size. The sum of the weights of these food items consumed, rather 
than their flavonoid or cocoa content, formed the measure of exposure.  Chocolate intake 
ranged from 0-348 g/d.  We excluded participants with chocolate intake greater than 100g/d 
(n=68), since generalization of the results to such high quantities seemed unjustified.  Equally, 
errors (i.e. outliers) relating to participant’s poor comprehension of FFQs in general, or 
specifically the questions on chocolate products, were hereby minimized. 
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Ascertainment of Heart Failure Incidence 
 Hospital admissions for participants were identified using the participant’s unique 
National Health Service number and linking this to the ENCORE (East Norfolk COmmission 
REcord) database. All participants were flagged for death certification at the UK Office of 
National Statistics, ascertaining vital status for the entire cohort. Incident heart failure cases 
were ascertained by using death certificate data and hospital record linkage using the 
“International Classification of Disease-10” (ICD10) code I50 with virtually complete follow 
up.22 Heart failure ascertainment has been previously validated and reported.25 We report 
data with follow-up up to March 2009, an average of 12.5 years. The study was approved by 
the Norwich District Health Authority Ethics Committee. All participants provided signed 
informed consent. 
 
Statistical analysis 
 Statistical analysis was conducted using STATA 14.0 (StatCorp, College Station, 
USA).  We categorized chocolate consumption into quintiles.  The participants in the first 
quintile consumed no chocolate.  Baseline characteristics were compared between the quintile 
groups of chocolate consumption using one-way analysis of variance (ANOVA) for 
continuous variables and chi-squared test for categorical variables. We excluded participants 
with prevalent baseline heart failure (where prevalent heart failure was defined using self-
reported intake of drugs recommended for heart failure at the time of the survey, essentially 
loop diuretics in combination with digitalis or angiotensin converting enzyme inhibitors 
[22,26]), cancer as well as participants with missing data on any of the variables included in 
the models (Supplementary Figure 1).  The bottom quintile (i.e. non-consumers) was used as 
the reference category for all risk estimates.  Hazard ratios and corresponding 95% confidence 
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intervals (95%CI) for the risk of incident heart failure were calculated using a Cox 
proportional hazards model.   
The five different levels of adjustment for confounders are described in Appendix 2. In 
brief, cumulative models were constructed to control for potential lifestyle factors and co-
morbid conditions (age, sex (model 1), lifestyle including dietary data: education, body mass 
index, social class, physical activity, smoking, dietary energy and alcohol consumption 
(model 2) and medical conditions that may contribute to the pathogenesis of heart failure: 
diabetes, myocardial infarction and arrhythmias (model3)).  We included other potential 
mediators (systolic blood pressure, cholesterol levels and heart rate [22]) in models 4a, b, and 
c, respectively. We then performed stratified analysis using model 3 for subgroups of 
participants based on: sex, age (<65 vs ≥65 years), body mass index (<25 vs ≥25 kg/m2), 
physical activity (active vs non-active), energy intake (<median energy vs ≥median energy), 
prior myocardial infarction, prior diabetes and prior arrhythmia.  We formally tested for 
interaction by comparing the model with and without interaction term using the P-value of the 
likelihood ratio test (LRT).  The interaction terms were presented graphically.   
We also conducted a sensitivity analysis excluding participants who had incident heart 
failure within the first 3 years of the follow-up. 
 
Systematic review and meta-analysis 
 We aimed to identify studies that reported on the association between chocolate 
consumption and incident heart failure. We searched PubMed and EMBASE from inception 
until December 2013 using the terms (cocoa OR chocolate) AND (heart failure OR cardiac 
failure OR congestive cardiac failure OR left ventricular dysfunction), with no language 
restrictions and we checked bibliographies of included articles. We set up an automated 
search on PubMed for updates (most recent April 2015) on newly published studies with 
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terms such as ‘chocolate’ and ‘heart or cardiac or cardiovascular’. We also performed a search 
of ESC 365 for unpublished studies.  Two reviewers independently screened abstracts and 
titles, and then obtained full-text versions of potentially relevant studies to confirm eligibility.  
Studies were included if they evaluated chocolate intake and incident heart failure.  Data 
extraction of included studies was performed by CSK and this was checked by YKL. We 
pooled data using the inverse variance method and random effects model in RevMan 5.2 
software (Nordic Cochrane Center, Copenhagen, Denmark). For these comparisons, we 
considered subgroups of women, men, both genders combined and all studies irrespective of 
gender. We used the multivariable adjusted measures of association (hazard ratios, relative 
risks or odds ratios) for the highest category of chocolate consumption versus the lowest 
category of consumption. Heterogeneity was estimated using I
2
 where values greater than 
50% were considered to have substantial heterogeneity [27].  In the case where a pooled 
estimate from meta-analysis contained more than 10 studies and there was no evidence of 
significant heterogeneity, we intended to evaluate publication bias using asymmetry testing in 
accordance to the recommendations by Ioannidis et al [28].  
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Results 
EPIC-Norfolk Study  
 After excluding participants with prevalent cancer and heart failure at the baseline, a 
total of 20,922 participants, 9,738 men and 11,184 women were included in the study 
(Appendix 3). The cohort’s mean age at baseline was 58.0±9.0 years and 53% were women. 
The mean follow up was 12.5± 2.7 years (total person years 262,291 years) during which 
1,101 individuals developed incident heart failure.  A total of 4,236 (20.3%) participants 
consumed no chocolate (less than once per month) in the past year. 
 The characteristics of participants according to quintiles of daily chocolate 
consumption are shown in Table 1.  The highest consumers of chocolate consumed more than 
15.5 g/d of chocolate while the participants in the bottom group consumed no chocolate.  
Higher chocolate consumption was significantly associated with a younger age and a lower 
systolic blood pressure, as well as a lower proportion of people with hypertension, myocardial 
infarction and diabetes, but associated with higher energy intake.  The overall rates of incident 
heart failure were lower with higher chocolate consumption; crude rates were 3.3 
events/1,000 years and 5.7 events/1,000 years in the highest and the lowest categories, 
respectively. 
Association between chocolate consumption and incident heart failure in the EPIC-Norfolk 
cohort 
 Table 2 shows that the highest chocolate consumption category was associated with 
lower risk estimates of incident heart failure in the age and sex adjusted model (HR 0.75 
95%CI 0.62-0.91).  However after adjustment for lifestyle factors and potential causal chronic 
co-morbidities, there was no significant difference between the highest consumers and no 
consumption of chocolate (HR 0.87 95%CI 0.71-1.06, Model 2).  Further adjustments for all 
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factors in a single model (Model 3), did not attenuate the results further and showed similar 
non-significant results (HR 0.87 95%CI 0.71-1.06). 
 Secondary analyses were conducted considering subgroups of participants (Table 3).  
The highest consumers of chocolate were associated with a lower risk of heart failure in the 
subgroup of participants with energy intake below the median (HR 0.68 95%CI 0.47-0.97).    
Models including an interaction term did not show significant improvement compared to 
model 3 in the prediction of incident heart failure (Appendix 4). In sensitivity analysis, we 
excluded participants with incident heart failure during the first 3 years (n=88) and observed 
similar results (data not shown).   
 
Systematic review & Meta-analysis  
Our search yielded 50 potentially relevant articles and 10 conference presentations.  
From these results, 4 studies met the inclusion criteria (Figure 1).  Details of the included 
studies are shown in Table 4.  Two of the four studies were observational [15,17] and two 
were post-hoc analysis of randomized trials [16,18].  Two studies only included women 
[15,16] one of which was conducted in women who underwent mammography [15], and the 
other one was conducted in women who were  randomized to calcium therapy [16], one 
included only male physicians [18].  The remaining study included participants after 
myocardial infarction [17].  One study excluded participants with previous myocardial 
infarction [15]. Incident heart failure outcomes were standardized using International 
Classification of Disease codes in three studies. 
All four studies used questionnaires to ascertain chocolate consumption, but there was 
heterogeneity in the way chocolate consumption was analyzed as one study considered 
frequency of chocolate consumption (monthly, weekly, two or more times weekly) [17], 
another compared one or more servings a week [16] and the others compared different 
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number of servings (1-3 servings/month, 1-2 servings/week, 3-6 servings/week, ≥1 
serving/day) [15,18].  While all studies made some adjustments for confounders, age was 
adjusted for in all studies but smoking, exercise/physical activity and alcohol consumption 
were adjusted in three studies only [15,17,18]. 
 The pooled results of all the studies suggest that overall chocolate consumption was 
associated with a 19% relative risk reduction in in incident heart failure but did not reach 
statistical significance (RR 0.81 95%CI 0.66-1.01, I
2
=46%) (Figure 2).  Considering the 
subgroups in Figure 1 there were similar non-significant reductions in incident heart failure.  
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Discussion  
 In this large prospective population based cohort study, systematic review and meta-
analysis, we found the association between chocolate consumption and reduced subsequent 
risk of heart failure but this was not sufficiently robust after adjusting for potential 
confounders.  This applied to men and women as well as those with or without baseline heart 
failure risk factors such as myocardial infarction, diabetes and arrhythmias.  Considering 
these results in the context of existing studies, there appears to be consistent findings across 
all studies that chocolate consumption does not increase the risk of incident heart failure.  We 
observed modest heterogeneity across studies and no significant association.   
The EPIC-Norfolk cohort represents an apparently healthy middle and older age 
community dwelling population and thus the current study addresses previous limitations 
such as data from specific patient populations, or focused on a particular sex with certain 
characteristics and risk profile [15-18].   
 Previous mechanistic studies have suggested that chocolate consumption could lower 
the risk of incident heart failure through several pathways.  Cocoa is rich in flavonoids which 
are believed to be responsible for the cardioprotective properties of chocolate. Flammer et al 
randomized participants with heart failure to flavanol-rich chocolate or placebo and found that 
chocolate led to peripheral vasodilatation, improvement in endothelial function and inhibition 
of platelet function [29]. However, their study was limited due to small sample size and thus 
no conclusive evidence was drawn for other outcomes such as blood pressure and measures of 
oxidative stress. A meta-analysis of ten randomized controlled trials has found that flavanol-
rich cocoa products have the capacity to lower blood pressure [1]. This blood pressure 
reduction was thought to be due to flavanol inhibition of angiotensin converting enzyme.5 
Given the fact that ACE inhibitors are the cornerstone medical therapy for heart failure, this 
effect may be relevant in the observed association with heart failure incidence. In addition, a 
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small randomized study has suggested that cocoa powder and dark chocolate consumption 
may modestly reduce LDL oxidation susceptibility, increase serum total antioxidant capacity 
and HDL cholesterol concentrations [30].  
There is also evidence to suggest that chocolate has anti-inflammatory[13] and 
antiplatelet properties [31,32]. Studies of dark chocolate have further provided evidence that 
consumption of chocolate improves endothelial function [33], increases levels of HDL 
cholesterol concentration [11] and lower levels of inflammation in the serum [12]. However, a 
recent study investigating the impact of dietary flavan-3-ol intake in the EPIC-Norfolk cohort 
suggests that the dose is insufficient to confer cardiovascular benefit so other mechanisms 
must account for the current findings [34].  Although we found trends towards non-significant 
relative risk reduction, reverse causality remains the main possible explanation. We observed 
that among lower categories of chocolate consumption there were more people with 
hypertension, previous myocardial infarction and diabetes.  It may be that these participants 
with cardiovascular risk factors consumed less chocolate. 
 It should be noted that the chocolate consumption in the EPIC-Norfolk was skewed 
(the median consumption (IQR) was 4.6 (0.56-12) and we also truncated chocolate 
consumption at max of 100g/d to exclude outliers. We thus further examined the effect of 
incremental increase in chocolate consumption and incident heart failure and there was no 
evidence for harm (data not shown).  We have recently reported that chocolate consumption 
was associated with favorable cardiovascular outcomes [14].  What remains controversial is 
that while the benefits of chocolate appear to be in those in the top quintiles of chocolate 
consumption, commercially available chocolate has high calorie content thus when consumed 
in high quantity may have adverse consequences because of increased weight gain [35,36] 
and diabetes [37].  Therefore, it is possible that in some people the potential benefits of 
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chocolate outweigh the consequences of increased caloric intake with resultant adverse effects 
such as poor diabetes control leading to complications.    
While all studies used food frequency questionnaires to estimate chocolate 
consumption, we note that chocolate intake had no consistent definition across the studies. 
Most of the studies considered chocolate from chocolate bars while the study by Lewis et al. 
considered only solid chocolate and chocolate containing beverages [16].  In the current 
study, chocolate intake was derived from chocolate singles, chocolate bars and chocolate 
beverages.  There was additional heterogeneity in the way the chocolate intake was 
categorized.  Lewis et al. categorized chocolate intake from <1 serving/week to ≥7 
servings/week [16].  In the study by Mostofsky et al [15], there were 8 predefined responses 
ranging from never to ≥3 times per day for chocolate intake and Janszky used similar 
definitions [17].  Petrone et al used frequency across the year from never or less than once per 
month to up to 5 times weekly [18].  In the current study, we analysed the data according to 
quintiles of chocolate intake. 
We observed that among the highest consumers of chocolate who had energy intake 
below the median had a lower risk of heart failure.  It is unclear why this is. One possible 
reason for this observation may be that low energy intake may reflect individuals who are of 
younger age and younger age is associated with lower heart failure risk. 
 While we found that chocolate intake may possibly be associated with lower 
likelihood of heart failure, the association was not statistically significant after adjustments 
for potential confounders and mediators.  There could still be a significant association but this 
study may not have had sufficient sample size and power to detect this.  This is supported by 
the meta-analysis which pooled existing studies which all seem to suggest a lower risk in 
heart failure with higher chocolate consumption.  However, the positive associations from 
published literature may also stem from publication bias whereby studies that show 
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significant associations are more likely to be published whereas those with null or non-
significant findings remain unpublished.  More studies with high quality methods and 
adequately powered sample size are needed to determine if there are benefits of chocolate in 
terms of heart failure risk. 
 Our study has several strengths.  The current study is based on a large population-
based cohort thus is applicable to the middle and older aged general population.  The 
characteristics of the EPIC-Norfolk participants were comparable to other UK representative 
samples except with lower prevalence of current smokers [18]. The sample size was 
sufficiently large to capture a sufficient number of incident heart failure events.  Furthermore, 
we were able to account for many potential confounders including, socio-demographic, 
lifestyle, physiological, co-morbidity and dietary factors, which increased the robustness of 
our findings.  In addition, clinically significant incident heart failure cases were adequately 
ascertained from hospital admissions38 and death certificates.  Furthermore, we conducted a 
systematic review to evaluate how our results compare with the existing literature and able to 
quantify the evidence by conducting a meta-analysis of similar studies. 
 Our study has some limitations.  The FFQ has limitations associated with it such as 
assumptions about portion size, possible errors in completing the questionnaire due to 
memory and extended recall time of 1 year.  Some participants may under report especially 
with chocolate consumption. This could mean that the high chocolate consumers are people 
with more ‘reliable chocolate intakes’ and possibly with other positive behaviors or 
characteristics which lower risk of a cardiac outcome.  We were unable to differentiate plain, 
milk and dark chocolate in this study and therefore unable to determine the effect of the 
different types of chocolate.  Mild cases of heart failure might have been missed at baseline. 
However, sensitivity analysis excluding those diagnosed with heart failure within the first 3 
years of follow up did not alter the results.  Studies have shown that many patients with left 
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ventricular systolic dysfunction are asymptomatic, undetected and untreated [39,40]. 
However, the use of hospital records would identify the most clinically relevant cases of heart 
failure.   The evaluation of chocolate across all studies included in our systematic review 
lacked consistency defining high or low intake and also varied in ascertaining chocolate 
consumption which introduced modestly high heterogeneity in the meta-analysis.   
 It is worth noting that while chocolate consumption may be associated with potential 
cardiovascular benefit with regard to incidence of stroke and ischemic cardiovascular disease; 
the different pathophysiological process which underpins the development and progression of 
heart failure is very different from ischemic pathology. The initial inverse association 
between higher chocolate consumption and incident heart failure was attenuated by 
adjustment of confounders and potential mediators. Nevertheless, we observed an unlikely 
increased harm from higher chocolate consumption with regard to the risk of developing 
subsequent heart failure in this general population. 
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Table 1: Sample characteristics by chocolate intake of 20,922 men and women of the EPIC-Norfolk cohort at the study baseline (1993-1997) and 
incident heart failure at respective follow up March 2009 
Quintiles of daily chocolate 
intake 
Quintile 1 
(n=4,236) 
Quintile 2  
(n=3,521) 
Quintile 3 
(n=4,386) 
Quintile 4 
(n=4,582) 
Quintile 5 
(n=4,198) 
p-
value* 
Range (g/day) 0 0.6-3.4 3.5-6.9 7.0-15.5 15.6-98.8  
Median  (IQR) (g/day) 
      Chocolate intake 
      Chocolate singles 
      Chocolate bars 
      Chocolate beverages 
 
0 
0 
0 
0 
 
0.8 (0.6, 1.4) 
0.6 (0.6,1.1) 
0 
0 (0, 0.8) 
 
4.1 (4.1, 4.9) 
0.6 (0, 1.1) 
3.5 (3.5, 3.5) 
0 (0, 0.8) 
 
8.7 (8.0, 12.0) 
1.1 (0, 3.4) 
7.0 (3.5, 7.0) 
0 (0, 5.2) 
 
24.9 (22.1, 39.5) 
1.1 (0.6, 3.4) 
21.5 (21.5, 21.5) 
0 (0, 5.2) 
 
Sex, women 53 (2,236) 56 (1,962) 56 (2,441) 54 (2,455) 50 (2,090) <0.001 
Age, years 60±9 60±9 57±9 58±9 57±9 <0.001 
Body mass index, kg/m
2
 26.4±4.0 26.2±3.8 26.3±3.6 26.2±3.8 26.1±3.7 <0.001 
Current smoker 10 (428) 10 (369) 11 (486) 12 (547) 13 (564) <0.001 
Self-reported diabetes  6 (235) 2 (60) 1 (60) 1 (47) 1 (31) <0.001 
Self-reported hypertension 16 (691) 14 (494) 13 (590) 13 (587) 12 (495) <0.001 
Self-reported myocardial 
infarction  
4 (168) 3 (108) 2 (108) 2 (114) 2 (92) <0.001 
Self-reported arrhythmia  6 (239) 6 (194) 4 (190) 5 (225) 5 (213) 0.050 
Total cholesterol, mmol/L 6.2±1.2 6.2±1.1 6.1±1.1 6.2±1.2 6.1±1.2 <0.001 
Systolic blood pressure, 
mmHg 
137±18 136±18 135±18 135±18 134±17 <0.001 
Heart rate, beats/minute 71±12 71±12 70±12 71±12 71±11 0.79 
Social class      <0.001 
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       I 
       II 
       III non-manual 
       III manual 
       IV 
       V 
6 (268) 
34 (1,429) 
16 (685) 
25 (1,041) 
15 (630) 
4 (183) 
8 (285) 
41 (1,433) 
17 (590) 
20 (712) 
11 (398) 
3 (103) 
7 (318) 
39 (1,698) 
16 (692) 
23 (1,008) 
13 (562) 
2 (108) 
7 (333) 
35 (1,630) 
16 (754) 
23 (1,078) 
13 (618) 
4 (168) 
6 (271) 
36 (1,496) 
17 (739) 
24 (996) 
13 (556) 
3 (140) 
Education 
       No qualification 
       O-level 
       A-level 
       Degree or higher 
 
40 (1,702) 
10 (420) 
40 (1,682) 
10 (432) 
 
34 (1,181) 
10 (365) 
41 (1,440) 
15 (535) 
 
34 (1,499) 
11 (464) 
41 (1,799) 
14 (624) 
 
35 (1,616) 
11 (514) 
41 (1,867) 
13 (584) 
 
34 (1,445) 
11 (448) 
43 (1,784) 
12 (521) 
<0.001 
Physical activity 
       Inactive 
       Moderately inactive 
       Moderately active 
       Active 
 
34 (1,420) 
27 (1,153) 
21 (907) 
18 (756) 
 
29 (1,037) 
30 (1,070) 
23 (818) 
17 (596) 
 
27 (1,196) 
29 (1,283) 
24 (1,057) 
19 (850) 
 
27 (1,256) 
30 (1,375) 
23 (1,048) 
20 (902) 
 
28 (1,158) 
28 (1,167) 
24 (1,023) 
20 (850) 
<0.001 
Energy intake by FFQ, kJ/day 7812±2291 8104±2265 8339±2309 8928±2411 9926±2666 <0.001 
Alcohol by FFQ, g/day 8.8±14.4 9.3±13.0 9.2±13.1 8.3±12.0 8.4±12.2 <0.001 
Incident heart failure 7 (302) 6 (201) 5 (206) 5 (221) 4 (171) <0.001 
Data are presented as mean±SD, percentage (number) or median (IQR). 
*P-value determined by analysis of variance (ANOVA) for continuous variables and χ2 test for categorical variables for differences among 
groups. 
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Table 2: Hazard Ratios for incident heart failure outcome in 20,922 men and women of the EPIC-Norfolk cohort by chocolate consumption 
Quintiles of daily 
chocolate intake 
Quintile 1 
0 g/day  
(n=4,236) 
Quintile 2   
0.6-3.4 g/day  
(n=3,521) 
Quintile 3  
3.5-6.9 g/day 
(n=4,386) 
Quintile 4 
7.0-15.5 g/day 
(n=4,582) 
Quintile 5  
15.6-98.8 g/day 
(n=4,198) 
p-value 
for trend 
across 
median 
chocolate 
intake in 
each 
group 
Model 1 1.00 (ref) 0.83 (0.69-0.99) 0.87 (0.73-1.03) 0.78 (0.66-0.93) 0.75 (0.62-0.91) 0.013 
Model 2 1.00 (ref) 0.93 (0.78-1.11) 0.97 (0.81-1.16) 0.89 (0.74-1.06) 0.87 (0.71-1.06) 0.193 
Model 3 1.00 (ref) 0.92 (0.77-1.11) 0.96 (0.80-1.15) 0.89 (0.74-1.06) 0.87 (0.71-1.06) 0.194 
Model 1: Age, sex adjusted 
Model 2: Age, sex, education, body mass index (per unit), social class, physical activity, smoking status, dietary energy (per kJ/day), alcohol 
consumption (per g/day), myocardial infarction, diabetes, arrhythmia adjusted  
Model 3: Age, sex, education, body mass index (per unit), social class, physical activity, smoking status, dietary energy (per kJ/day), alcohol 
consumption (per g/day), myocardial infarction, diabetes, arrhythmia, systolic blood pressure (per mmHg), cholesterol level (per mmol/L), heart 
rate (per beat) adjusted 
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Table 3: Subgroup analysis with hazard ratios for incident heart failure outcome in 20,922 men and women of the EPIC-Norfolk cohort by 
chocolate consumption  
Quintiles of daily 
chocolate intake 
Quintile 1 
0 g/day  
Quintile 2   
0.6-3.4 g/day  
Quintile 3  
3.5-6.9 g/day 
Quintile 4 
7.0-15.5 g/day 
Quintile 5  
15.6-98.8 g/day 
Likelihood 
–ratio test 
p-value* 
Female 
(n=11,184) 
Male   
(n=9,738) 
1.00 (ref) 
 
1.00 (ref) 
0.97 (0.72-1.31) 
 
0.92 (0.73-1.16) 
0.96 (0.72-1.30) 
 
0.97 (0.78-1.22) 
0.89 (0.66-1.21) 
 
0.90 (0.72-1.13) 
0.83 (0.59-1.16) 
 
0.89 (0.69-1.14) 
0.97 
Age <65 years 
(n=14,696) 
Age ≥65 years 
(n=6,226) 
1.00 (ref) 
 
1.00 (ref) 
0.90 (0.63-1.29) 
 
0.96 (0.78-1.18) 
0.85 (0.62-1.18) 
 
0.93 (0.75-1.15) 
0.83 (0.59-1.16) 
 
0.89 (0.72-1.09) 
0.74 (0.52-1.05) 
 
0.82 (0.66-1.06) 
0.56 
BMI <25 km/m
2
  
(n=8,379) 
BMI ≥25 km/m2  
(n=12,543) 
1.00 (ref) 
 
1.00 (ref) 
1.26 (0.91-1.75) 
 
0.83 (0.67-1.03) 
 
1.14 (0.81-1.63) 
 
0.91 (0.74-1.13) 
 
0.95 (0.66-1.35) 
 
0.87 (0.71-1.07) 
 
1.09 (0.76-1.56) 
 
0.79 (0.62-1.00) 
0.38 
 
 
Inactive 
(n=12,115) 
Active  
(n=8,807) 
1.00 (ref) 
 
1.00 (ref) 
0.87 (0.70-1.08) 
 
1.12 (0.79-1.58) 
0.91 (0.74-1.13) 
 
1.12 (0.79-1.57) 
0.87 (0.70-1.07) 
 
0.95 (0.67-1.34) 
0.86 (0.68-1.09) 
 
0.91 (0.62-1.33) 
0.99 
Low energy intake  
(n=10,457) 
High energy intake  
(n=10,465) 
1.00 (ref) 
 
1.00 (ref) 
0.89 (0.70-1.13) 
 
0.97 (0.74-1.29) 
0.90 (0.71-1.15) 
 
1.04 (0.79-1.35) 
0.76 (0.59-0.99) 
 
0.95 (0.74-1.22) 
0.68 (0.47-0.97) 
 
0.93 (0.72-1.20) 
0.58 
No prior MI 
(n=20,332) 
Prior MI  
(n=590) 
1.00 (ref) 
 
1.00 (ref) 
0.96 (0.79-1.16) 
 
0.80 (0.47-1.34) 
0.98 (0.81-1.19) 
 
0.93 (0.58-1.49) 
0.91 (0.75-1.10) 
 
0.76 (0.46-1.28) 
0.88 (0.71-1.09) 
 
0.78 (0.43-1.42) 
0.98 
No prior diabetes 
(n=20,489) 
1.00 (ref) 
 
0.95 (0.79-1.15) 
 
1.01 (0.84-1.22) 
 
0.91 (0.75-1.09) 
 
0.90 (0.73-1.10) 
 
0.55 
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Prior diabetes  
(n=433) 
1.00 (ref) 0.93 (0.49-1.77) 0.54 (0.25-1.20) 0.74 (0.34-1.61) 0.50 (0.15-1.65) 
No prior arrhythmia 
(n=19,861) 
Prior arrhythmia 
(n=1,061) 
1.00 (ref) 
 
1.00 (ref) 
0.96 (0.79-1.17) 
 
0.69 (0.40-1.17) 
1.03 (0.85-1.24) 
 
0.55 (0.30-1.01) 
0.92 (0.76-1.11) 
 
0.81 (0.47-1.38) 
0.89 (0.72-1.10) 
 
0.76 (0.44-1.32) 
0.45 
Adjusted for age, sex, education, body mass index (per unit), social class, physical activity, smoking status, dietary energy (per kJ/day), alcohol 
consumption (per g/day), myocardial infarction, diabetes, and arrhythmia. 
* P-value reflects the comparison of the models without and with the interaction term (Please note, the HR presented in the table are from the 
stratified analysis). 
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Table 4: Studies of chocolate and heart failure 
Study Design, Country Types of 
participants 
Number of 
participants 
Exposure 
ascertainment 
Outcome 
ascertainment 
Use of adjustments Results 
Janszky 
2009 [17] 
Cohort study, 
Sweden 
Non-diabetic 
participants post 
acute myocardial 
infarction in 
Stockholm Heart 
Epidemiology 
Program. 
1,169 Self-reported 
usual chocolate 
consumption.  
Congestive heart 
failure events  
based on ICD-9 and 
10 codes. 
Adjusted for age, sex, 
smoking, obesity, physical 
inactivity, alcohol use, 
coffee intake, education 
and sweet score. 
Congestive heart failure with 
less than once per month 
chocolate adjusted HR 0.82 
(0.56-1.19), up to once per week 
chocolate adjusted HR 0.68 
(0.47-0.97), twice or more a 
week chocolate adjusted HR 
0.78 (0.52-1.16) compared to 
never consumption of chocolate. 
Lewis 2010 
[16] 
Post-hoc 
analysis of 
RCT, Australia 
Older women 
randomized to 
calcium 
supplementation. 
1,216 Chocolate 
consumption 
using validated 
questionnaire.  
Heart failure events 
based on ICD-10-
AM codes. 
Adjusted for age, body 
mass index, socioeconomic 
status and energy intake. 
Chocolate serving/week ≥1 vs 
<1: event rate 18/637 (2.8%) vs 
35/579 (6%); adjusted OR 0.41 
0.22-0.76, p=0.01. 
Mostofsky 
2010 [15] 
Cohort study, 
Sweden 
Middle-aged and 
elderly women in 
Swedish 
Mammography 
Cohort. 
31,823 Chocolate 
consumption 
using food 
frequency 
questionnaire. 
Heart failure events 
based on ICD-9 and 
10 codes. 
Adjusted for total energy, 
age, education, body mass 
index, physical activity, 
smoking, living alone, 
postmenopausal hormone 
use, alcohol consumption, 
family history, 
hypertension and high 
cholesterol. 
Chocolate vs no chocolate: 1-3 
serving/month HR 0.74 (0.58-
0.95), 1-2 serving/week HR 
0.68 (0.50-0.93), 3-6 
servings/week HR 1.09 (0.74-
1.62), ≥1 serving/day HR 1.23 
(0.73-2.08). 
Petrone 
2014 [18] 
Post-hoc 
analysis of 
RCT, USA. 
US male physicians 
who were 
randomized to low-
dose aspirin. β-
carotene, vitamin C, 
E and multivitamin 
in the Physicians' 
Health Study. 
20,278 Chocolate 
consumption 
using food 
frequency 
questionnaire. 
Heart failure based 
on annual follow-up 
questionnaires 
mailed to each 
participant and 
diagnoses were 
previously 
validated by 
reviewing medical 
records in a 
subsample. 
Adjusted for age, BMI, 
alcohol consumption, 
smoking, exercise, caloric 
intake and prevalent atrial 
fibrillation. 
Chocolate intake frequency and 
heart failure (Model 1): 
Never or <1/month: HR 1.00 
1-3/month: HR 0.86 (0.72-1.03) 
1/ week: HR 0.80 (0.66-0.98) 
2-4/week: HR 0.92 (0.74-1.13) 
5+/week: HR 0.82 (0.63-1.07) 
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Current 
study 
Cohort study, 
United 
Kingdom 
General population. 20,987 Chocolate 
consumption 
based on food 
frequency 
questionnaire.  
Incident heart 
failure events based 
on linkage to 
admissions 
database. 
Adjusted for age, 
education level, social 
class, physical activity, 
smoking status, body mass 
index, myocardial 
infarction, diabetes, 
arrhythmia, dietary energy 
and alcohol consumption. 
Chocolate consumption in 
highest vs lowest quintile: entire 
cohort adjusted HR 0.85 95% 
CI 0.71-1.05.  Subgroup of 
women adjusted HR 0.81 (0.58-
1.13) and subgroup of men 
adjusted HR 0.89 (0.69-1.14). 
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Figure 1: Search strategy and study selection 
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Figure 2: Meta-analysis of chocolate consumption and incident heart failure 
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Appendix 1: Description of data collection 
 Education status was recorded as degree or equivalent, A-level or equivalent, O-level 
or equivalent, and less than O-level or no qualifications [1]. Social class was classified 
according to the Registrar General’s occupation-based classification scheme where social 
class I consists of professionals (e.g. Doctors and lawyers), class II includes managerial and 
technical occupations, class III is subdivided into non-manual and manual skilled workers (III 
non-manual and III manual), class IV consist of partly skilled workers, and class V comprises 
of unskilled manual workers [1].
 
Physical activity was assessed with two questions referring 
to usual physical activity at work, and physical activity outside work, during the past year [1].   
The responses to these questions were used to allocate participants as: inactive (sedentary job 
and no recreational activity), moderately inactive (sedentary job with <0.5 hours recreational 
activity per day or standing job with no recreational activity), moderately active (sedentary 
job with 0.5 to 1 hour recreational activity per day or standing job with <0.5 hour recreational 
activity per day or physical job with no recreational activity); and active (sedentary job with 
>1 hour recreational activity per day or standing job with >1 hour recreational activity per day 
or physical job with at least some recreational activity or heavy manual job). 
 Smoking history was obtained from yes–no responses to the questions: “Have you 
ever smoked as much as one cigarette a day for as long as a year?” and “Do you smoke 
cigarettes now?” and the responses were used to categorize participants as never or former 
smokers and current smokers [2].
 
Trained nurses examined each participant at a clinic visit. 
Height and weight were measured, and body mass index (BMI) was estimated as weight (kg) 
divided by height squared (m
2
) [3]. Blood pressure and heart rate were measured twice with 
an Accutorr non-invasive blood pressure monitor (Datascope Medical, Huntington, UK) after 
the participant had been seated for 5 min and the mean of two measurements was used for the 
analysis [3]. 
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 Blood samples were obtained using standard protocols and plasma was stored at -70°C 
before total cholesterol concentrations were measured by colorimetry (RA 1000; Bayer 
Diagnostics, Basingstoke, UK) [1].
 
LDL cholesterol was calculated by the Friedewald 
formula. Participants were asked the question, “Has the doctor ever told you that you have 
any of the following?” and this was followed by a checklist to include myocardial infarction, 
cancer, diabetes and arrhythmia in order to identify known co-morbidities [1]. 
 A food frequency questionnaire (FFQ) was used to assess overall diet in the past year.  
Food items in the questionnaire had nine answer categories: never or less than once per 
month, 1-3 per month, once a week, 2-4 per week, 5-6 per week, once a day, 2-3 per day, 4-5 
per day, 6+ per day.  This instrument and the way it is analysed using the Compositional 
Analyses from Frequency Estimates (CAFÉ) and FFQ EPIC Tool for Analysis (FETA), are 
described in detail elsewhere [4,5].
 
Alcohol consumption was derived from a questionnaire 
containing selected foods collected at the baseline clinic visit and the average alcohol 
consumption in grams/day was calculated [1].
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Appendix 2: Description of adjustments  
 Regression model 1 adjusted for age and sex only. Regression model 2 adjusted for 
age, education (4 categories: degree or equivalent, A-level or equivalent, O-level or 
equivalent, and less than O-level or no qualifications), social class (6 categories: class I 
consists of professionals, class II includes managerial and technical occupations, class III is 
subdivided into non-manual and manual skilled workers (III non-manual and III manual), 
class IV consist of partly skilled workers, and class V comprises of unskilled manual 
workers), physical activity (4 categories: inactive, moderately inactive, moderately active and 
active), dietary energy (kJ/day), body mass index (per unit), alcohol consumption (g/day) and 
current smoking which are important potential confounders with regard to habitual chocolate 
consumption. Regression model 3 adjusted for same variables as model 2 with the addition of 
diabetes, previous myocardial infarction and arrhythmia.  Regression model 4 adjusted for all 
variables in model 3 but included the mediator systolic blood pressure (per mmHg) in 4a, 
serum cholesterol levels (per mmol/L) in 4b and pulse rate (per beat) in 4c.  Regression model 
5 is the complete model which adjusted for all factors in models 2-4. 
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Appendix 3: Flow diagram of participant inclusion 
 
 
  
Total participants in the EPIC-Norfolk 
Cohort (N=25,639). 
Sample size after exclusion for heart 
failure and cancer (N=24,045). 
 
Final sample size after exclusion for 
missing data (N=20,922). 
 
Participants with prevalent heart failure 
(N=213) and cancer (N=1,381). 
Participants with missing chocolate 
(N=816), chocolate >100 g/day (N=68), 
missing social class (N=492), 
education level (N=2), physical activity 
(N=1), smoking (N=163), systolic BP 
(N=47), heart rate (N=11), BMI (N=40), 
cholesterol levels (N=1,450), previous 
myocardial infarction (N=16), diabetes 
N=14), arrhythmia (N=2), heart failure 
follow up time (N=1). 
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Appendix 4: Interaction terms for subgroup analysis of chocolate and risk of incident heart 
failure 
 
A) Gender interactions 
 
 
B) Age interactions 
 
 
C) BMI interactions 
 
37 
 
D) Physical activity interactions 
 
 
E) Energy intake interactions 
  
 
